Disease Info Card

Gangliosidoses, Gm2

Information about Gangliosidoses, Gm2: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Gangliosidoses, Gm2

Most recent studies have shown that Gangliosidoses, Gm2 shares some biological mechanisms with ataxia, atrophy, gangliosidoses, gangliosidosis-gm1, gaucher-disease, juvenile-gm>2<-gangliosidosis, leukodystrophy, leukodystrophy-metachromatic, lipoidosis, lysosomal-storage-diseases, muscular-atrophy, nerve-degeneration, nervous-system-disorder, nervousness, neurodegenerative-disorders, niemann-pick-diseases, sandhoff-disease, storage-disease, tay-sachs-disease, tay-sachs-disease-ab-variant.

Among the many pathways, these few ones have gauged particular interests from scientists studying Gangliosidoses, Gm2, and have been seen in publications frequently: Brain Development, Cell Death, Conjugation, Endocytosis, Glycolipid Transport, Glycosylation, Inflammatory Response, Intracellular Transport, Lipid Storage, Localization, Mating, Mrna Splicing, Muscle Atrophy, Myelination, Pathogenesis, Reflex, Reverse Transcription, Secretion, Startle Response, Transport

Quite a number of genes have been found to play important roles in Gangliosidoses, Gm2, such as BBS9, CAT, CRAT, ETFA, GLYAT, GM2A, HEXA, HEXB, HHEX, MS4A1, MTCH1, PSAP, QPCT, RANGAP1, SPANXB1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.